Celldex Therapeutics
CLDX
#5062
Rank
HK$9.98 B
Marketcap
HK$150.47
Share price
-5.93%
Change (1 day)
-62.10%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -HK$18.81

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$18.66. In 2022 the company made an earnings per share (EPS) of -HK$18.59 a decrease over its 2021 EPS that were of -HK$12.75.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$18.811.22%
2022-HK$18.5945.73%
2021-HK$12.75-23.36%
2020-HK$16.64-41.05%
2019-HK$28.23-76.95%
2018-HK$122.4845.03%
2017-HK$84.45-42.54%
2016-HK$146.97-3.82%
2015-HK$152.80-0.76%
2014-HK$153.9729.41%
2013-HK$118.980%
2012-HK$118.98-9.73%
2011-HK$131.811312.5%
2010-HK$9.33-95.79%
2009-HK$221.44-49.64%
2008-HK$439.74-82.64%
2007-HK$2,533-44.98%
2006-HK$4,6051270.83%
2005-HK$335.9333.33%
2004-HK$251.95-10%
2003-HK$279.94-16.67%
2002-HK$335.93-38.46%
2001-HK$545.89-4.88%
2000-HK$573.88-81.66%
1999-HK$3,128-87.2%
1998-HK$24,431206.39%
1997-HK$7,97413.02%
1996-HK$7,055

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$31.18 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$6.61-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$93.94 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$110.03-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$14.46-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$27.22-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-HK$4.43-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA